Back to Events List


Introduction to Early Access Programs

via Zoom
Friday 26 February 2021, 12.30 - 1.30pm

Webinar recording now available
Full BHBIA members only - you will need to log in to access it - once logged in, the link and password will appear on the page below this text.
Almost all EU markets have pathways that enable patients with serious, life threatening or debilitating diseases to access drugs in development prior to receiving marketing authorisation. This webinar will introduce early access programs (EAPs) and the benefits these programs can potentially bring to patients, clinicians and manufacturers. 

We will explore EAP pathways in the UK in more detail and compare these to pathways in other major European markets. To conclude, we will highlight some key considerations for designing primary and secondary research into EAPs.

Ultimately, this webinar will familiarise attendees with EAP terminology, provide an overview of the pathways to pathways in the UK and how this compares to other major European markets, as well as highlight key considerations when approaching EAP related research.

This webinar will be run by Partners4Access

Partners4Access is a specialist market access consulting company focussed on providing solutions for orphan drug, cell and gene therapy. We work closely with small, early stage biotechs and have considerable experience in advising on early access programmes (EAP) and their effectiveness in achieving launch success. The presenters are uniquely qualified to inform and educate on EAPs. 

We are very grateful to the team for giving their time and expertise for the benefit of BHBIA members.


Akshay Kumar has 13+ years of experience helping pharmaceutical and biotech companies develop market access & pricing solutions - which are aligned to their broader commercial, organisational and environmental context. These solutions could be at the product, process and/or capability level. Besides market access, Akshay also has supported pharmaceutical companies in allied commercial areas such as - epidemiology, opportunity assessments, product positioning, product performance tracking, customer insights, and organisational design. 

As a Consultant at Partners4Access, Max Rex has worked with a wide variety of pharmaceutical companies in the rare disease space. He has worked across a wide range of disease areas, providing critical insights to help companies with commercialisation strategies, HTA and stakeholder mapping, payer evidence requirements and insights, early access programs, innovative access models, and many more.

Max Rex | LinkedIn

Online booking:

Click on the register for event button below. Please note you must be logged in as a member to book online. 

If you belong to a BHBIA member company but don't yet have a log in please register now to join your company's membership.